back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-05-14 11:18 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-258.64
-212 vol $1.22 each |
3,683 | |
| Filed 2019-05-14 11:18 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$880.84
+722 vol $1.22 each |
3,895 | |
| Filed 2019-05-14 11:16 Tx date 2019-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-880.84
-722 vol $1.22 each |
47,982 | |
| Filed 2018-11-05 Tx date 2018-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-386.12
-98 vol $3.94 each |
||
| Filed 2018-11-05 Tx date 2018-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-622.50
-150 vol $4.15 each |
||
| Filed 2018-11-05 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-1,371.72
-322 vol $4.26 each |
||
| Filed 2018-11-05 Tx date 2018-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-386.12
-98 vol $3.94 each |
||
| Filed 2018-11-05 Tx date 2018-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-622.50
-150 vol $4.15 each |
||
| Filed 2018-11-05 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-1,371.72
-322 vol $4.26 each |
||
| Filed 2018-09-18 Tx date 2018-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-1,323.84
-336 vol $3.94 each |
48,704 | |
| Filed 2018-09-18 Tx date 2018-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,323
+336 vol $3.94 each |
3,271 | |
| Filed 2018-09-18 Tx date 2018-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-386.12
-98 vol $3.94 each |
3,173 | |
| Filed 2018-05-17 Tx date 2018-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-512 vol |
49,040 | |
| Filed 2018-05-17 Tx date 2018-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-150 vol |
2,935 | |
| Filed 2018-05-17 Tx date 2018-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+512 vol |
3,085 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-748 vol |
49,552 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-349 vol |
50,300 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-937.20
-220 vol $4.26 each |
2,573 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+748 vol |
2,793 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-434.52
-102 vol $4.26 each |
2,045 | |
| Filed 2018-05-11 Tx date 2018-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+349 vol |
2,147 | |
| Filed 2018-04-03 Tx date 2018-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-177 vol |
50,649 | |
| Filed 2018-04-03 Tx date 2018-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-182.00
-52 vol $3.50 each |
1,798 | |
| Filed 2018-04-03 Tx date 2018-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$182.00
+52 vol $3.50 each |
||
| Filed 2018-04-03 Tx date 2018-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$182.00
+52 vol $3.50 each |
||
| Filed 2018-04-03 Tx date 2018-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+177 vol |
1,850 | |
| Filed 2018-02-14 Tx date 2018-02-12 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
217,400 | |
| Filed 2017-10-10 Tx date 2017-10-06 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
172,400 | |
| Filed 2017-09-19 Tx date 2017-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-771.72
-109 vol $7.08 each |
1,673 | |
| Filed 2017-09-19 Tx date 2017-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+337 vol |
1,782 | |
| Filed 2017-09-19 Tx date 2017-09-17 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-337 vol |
50,826 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-717 vol |
51,163 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+717 vol |
1,677 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-2,081.04
-232 vol $8.97 each |
1,445 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-375 vol |
51,880 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-349 vol |
52,255 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,139.82
-121 vol $9.42 each |
960 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+375 vol |
1,081 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+349 vol |
819 | |
| Filed 2017-05-11 Tx date 2017-05-09 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,064.46
-113 vol $9.42 each |
706 | |
| Filed 2017-04-06 Tx date 2017-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
36 - Conversion or exchange
|
-178 vol |
52,604 | |
| Filed 2017-04-06 Tx date 2017-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-612.18
-57 vol $10.74 each |
470 | |
| Filed 2017-04-06 Tx date 2017-04-01 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+178 vol |
527 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+47,980 vol |
52,782 | |
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
37 - Stock split or consolidation
|
-19,210 vol |
4,802 | |
| Filed 2016-12-27 Tx date 2016-12-22 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+97,400 vol |
97,400 | |
| Filed 2016-12-27 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-27 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,398 vol |
349 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+7,486 vol |
24,012 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+5,230 vol |
16,526 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+2,564 vol |
11,296 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,777 vol |
8,732 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+3,589 vol |
6,955 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+3,366 vol |
3,366 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+1,747 vol |
1,747 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Harshbarger, Benjamin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|